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Abstract
Purpose Quantification of hepatic tracer kinetics by PET
requires measurement of tracer input from the hepatic artery
(HA) and portal vein (PV). We wished to develop a method
for estimating dual tracer input without the necessity to
sample PV blood.
Methods Pigs weighing 40 kg were given bolus doses of
C
15O (CO), 2-[
18F]fluoro-2-deoxy-D-glucose (FDG), [
11C]-
methylglucose (MG), 2-[
18F]fluoro-2-deoxy-D-galactose
(FDGal) or H2
15O( H 2O). Tracer concentration 3-min time
courses were measured in the femoral artery and PV by
blood sampling. Blood flow was measured in the HA and
PV using flow-meters. A model for transfer of tracer
through the splanchnic circulation was used to estimate
values of a tracer-specific model parameter β. Tracer-
specific mean values of β were used to estimate tracer
concentration time courses in the PV from the measured
arterial concentration. A model-derived dual-input was
calculated using the mean HA flow fraction (0.25) and
validated by comparison of the use of the measured dual-
input and a kinetic model with a fixed ”true” K1
true, i.e.
clearance of tracer from blood to liver cells.
Results The rank order of the means of β was CO<FDG≈
MG<FDGal<H2O, reflecting their different splanchnic
mean transit times. Estimated K1
est was not significantly
different from “true” K1
true.
Conclusion The hepatic dual tracer input, which is of great
importance for the assessment of processes such as transfer
across the plasma-hepatocyte membrane or hepatic blood
perfusion, can be well approximated in pigs without the
necessity to sample PV blood and measure hepatic blood
flow; only arterial blood sampling is needed.
Keywords Splanchnic circulation.Liver kinetics.
Molecular imaging.Pharmacokinetics.PET.Portal model.
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Abbreviations
CO [
15O]-Carbon monoxide
FDG 2-[
18F]Fluoro-2-deoxy-D-glucose
MG [
11C]Methylglucose
FDGal 2-[
18F]Fluoro-2-deoxy-D-galactose
H2O[
15O]-Water
HA Hepatic artery
PV Portal vein
FHA Blood flow in the hepatic artery (ml blood/min)
FPV Blood flow in the portal vein (ml blood/min)
fHA Hepatic arterial blood flow fraction
fHA Mean fHA for all experiments
h(t) Impulse-response function of the portal vein
model
β Tracer-specific parameter of the portal vein
model (min)
b Population mean of β for each tracer (min)
CA(t) Measured tracer concentration time-course
in peripheral arterial blood (kBq/ml blood)
CHA(t) Tracer concentration time course in hepatic
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CPV(t) Measured tracer concentration time course
in the portal vein (kBq/ml blood)
e CPVðtÞ PV model-derived tracer concentration time
course in the portal vein (kBq/ml blood)
Cdual(t) Measured dual-input tracer concentration
time course (kBq/ml blood)
e CdualðtÞ Model-derived dual-input tracer concentration
time course (kBq/ml blood)
Cliver(t) Measured activity concentration time course
in liver tissue (kBq/ml liver tissue versus min)
e CliverðtÞ Simulated activity concentration time course
in liver tissue (kBq/ml liver tissue versus min)
K1 Clearance of tracer from blood to liver cells
(ml blood/ml liver tissue/min)
Introduction
Molecular imaging with positron emission tomography
(PET) provides unique possibilities for in vivo quantifica-
tion of blood perfusion, transmembrane transport and tissue
metabolism. A quantitative PET study comprises bolus
administration of a positron-emitting tracer immediately
followed by dynamic recording of the tracer concentration
time-courses in tissue by PET and in the blood supply by
blood sampling. Physiological parameters are calculated by
fitting a mathematical model of tracer distribution and
metabolism to the data. Application of this approach to the
liver is complicated, however, due to dual input of tracer
from the hepatic artery (HA) and the portal vein (PV),
comprising 25% and 75%, respectively. The tracer concen-
tration time-course in the PV is initially delayed and
dispersed compared to that in the HA due to transfer of
tracer through the splanchnic circulation. If there is no
metabolism of the tracer in the organs drained by the PV,
hepatic steady-state metabolism may be assessed by
dynamic PET using solely the arterial input of tracer. This
has been validated for 2-[
18F]fluoro-2-deoxy-D-glucose
(FDG) [1, 2]a n d2 - [
18F]fluoro-2-deoxy-D-galactose
(FDGal) in pigs [3] and used in studies of hepatic FDG
metabolism in humans [4–6]. Processes such as transfer
across the highly permeable plasma-hepatocyte membrane
or hepatic blood perfusion must be assessed using the initial
dynamic part of tracer concentration time-courses before
steady-state metabolism dominates the recordings, however.
This requires successive measurement of blood tracer
activity concentration in the PV immediately after tracer
administration, as well as of the fractional blood flow in the
PV and HA [1]. The most reliable method is to measure
tracer concentration time-courses in both an artery and the
PV by invasive blood sampling combined with invasive
measurements of blood flow in the HA and PV. This is only
possible in animal studies, however [1–3, 7, 8], and various
studies have addressed the challenge of how to assess the
initial dynamic tracer input from the HA and PV for human
studies. Choi et al. [4] suggested the use of a single arterial
input with a time delay to account for the delay of the PV
input, but this does account for the dispersion of the PV
tracer input. However, Munk et al. [1] showed that
knowledge of the tracer input from both vessels, the so-
called dual-input, is needed to obtain unbiased kinetic
parameter estimates that are in agreement with independent
measurements of hepatic blood flow and hepatic blood
volume.
PET image-derived methods have been used in several
studies [9–12] and seem attractive because they are
completely noninvasive and thus applicable to humans.
However, the image-derived dual-input tracer concentration
time-course is prone to errors caused by partial volume
effects where the tracer concentration time-courses in the
PV and the aorta, used as arterial input, are affected by
tracer activity in the surrounding tissue due to limited
spatial resolution compared with the size of the vessels and
respiratory motion [4, 9, 10]. Mathematical–physiological
models describing the transfer of tracer from the intestinal
arteries to the PV do not rely on the dynamic tissue PET
image data. Various mathematical PV models have been
proposed such as a one-compartmental model [13] and a
double gamma-variate model [8].
We have previously developed PV models that included
only parameters with direct physiological interpretations
and which were validated by means of sets of measured
tracer concentration time-courses in arterial blood and the
PV [14]. However, these models have never been used to
calculate the dual-input for kinetic modelling of liver
physiology. One of these PV models (method 4 in ref. 14)
is particularly useful and robust for calculating the model-
derived tracer concentration time-course in the PV from
that in arterial blood as it provides a full description of the
tracer concentration time-course in the PV using only a
single tracer-specific parameter, β, which reflects tracer-
specific mean splanchnic transit time for the tracer from the
intestinal arteries to the PV. Therefore we tested the use of
this PV model in the present study.
The aim of the present study was to estimate population
means of β for five tracers with a wide range of mean
splanchnic transit times and to calculate the dual input from
the tracer-specific mean values of β and an estimated mean
of the HA blood flow fraction. The model-derived dual
input was validated by fitting a simple kinetic model to a
simulated tracer concentration time-course in liver tissue.
We chose clearance of tracer from blood to liver cells, K1,
as our test parameter because the K1 estimate is particularly
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curve [1]. Thus any errors produced by using the PV model
in kinetic modelling will be reflected in the estimated K1.
Moreover, K1 for MG, FDG and FDGal may be used as a
measure of hepatic blood perfusion [1, 3]. The overall aim
of the study was to develop and validate a simple method –
based solely on blood sampling from a peripheral artery,
tracer-specific means of β and an estimated mean HA blood
flow fraction – with which to estimate the combined tracer
input to the liver from the HA and PV for use in PET
studies of initial hepatic tracer kinetics.
Materials and methods
The investigations were performed in nine pigs given C
15O
(CO) by inhalation. Five of the pigs also received
intravenous injections of H2
15O( H 2O). In addition, the
study included analysis of raw data from previously
published studies in six pigs which each received intrave-
nous injections of FDG and [
11C]methylglucose (MG) [1],
and ten pigs which received intravenous injections of
FDGal [3]. In each study the tracer concentration time-
course was measured simultaneously in a femoral artery
and the PV, and blood flow was measured in the HA and
PV for the first 3 min following tracer administration using
surgically placed ultrasound transit time flow-meters.
All studies were approved by the Danish Ministry of
Legal Affairs and performed in accordance with European
Union, national, and institutional guidelines for animal
welfare.
Experimental procedures
Female pigs (Danish Landrace and Yorkshire cross-breed;
bodyweight38–42kg)werefastedfor16hwithfreeaccessto
water. Anaesthesia was maintained by a constant intravenous
infusion of 240 mg propofol, 200 mg S-ketamine and 40 mg
midazolam per hour and the animal was ventilated with air/
oxygen 2.2:1 by mechanical respiration. Catheters were
inserted into a femoral artery (blood sampling) and a femoral
vein (intravenous administration). The abdomen was opened
and ultrasound transit-time flow-meter probes (12 mm and 4
or 6 mm, respectively; CardioMed; In vivo Aps, Norway)
were positioned around the PV and HA (in some cases two
HA vessels) for continuous measurement of blood flow [15,
16]. A 5.3F polyethylene catheter (William Cook, Denmark)
was inserted directly into the PV for blood sampling; it was
placed downstream of the flow-meter probe so as not to
disturb the flow measurements. Physiological parameters
were maintained as follows: body temperature 38.5–39.5°C,
arterial pCO2 3.5–7.0 kPa, pO2 18.0–25.0 kPa, pH 7.35–
7.45 and blood glucose 5.0–6.7 mmol/l. The experiments
were terminated by intravenous injection of 4 g pentobarbital
sodium.
Tracer administration and blood concentration
measurements
C
15O (400 MBq) wasadministeredasa10-sinhalationviathe
respirator; H2
15O (300 MBq) was administered as a 15-s
intravenous injection. To assess reproducibility, these tracers
were administrated twice in each pig. Starting at the beginning
of tracer administration, arterial blood was drawn from the
catheter in the femoral artery by an automated blood sampling
apparatus and the blood concentration of tracer determined
every 0.5 s (Allogg, Mariefred, Sweden), correcting for delay
and dispersion in the sampling catheters [17]. In order not to
disturb blood flow in the HA, the samples were collected
from a femoral artery (the concentration of tracer in the
femoral artery is identical to that in the HA; Keiding,
unpublished observations). PV blood samples (1 ml) were
collected manually from the PV catheter every 5th second 18
times and then every 15th second 6 times (3 min). Tracer
concentrations in blood (kBq/ml) were measured using a well
counter (Packard Instruments, Meriden, CT). All tracer
concentration measurements were corrected for radioactive
decay back to the start of tracer administration.
With the FDG [1], MG [1] and FDGal [3] studies, tracer
concentrations were measured in successive blood samples
drawn manually from the femoral artery and PV over a
period of 45–90 min. However, in the present study only
measurements from the initial 3 minutes were used. For
none of the five tracers were metabolites detectable in the
blood [1, 3] and accordingly the measured tracer activity
concentrations in the blood were used directly in the
calculations.
Model considerations and calculations
With each administration of tracer the following calcula-
tions were performed:
1. The HA blood flow fraction, fHA, was calculated from
the flow-meter measurements of blood flow in the HA, FHA
(millilitres blood per minute), and in the PV, FPV (millilitres
blood per minute), as
fHA ¼ FHA= FHA þ FPV ðÞ ð 1Þ
The fHA in individual experiments deviated by less than
1% per minute, and an individual mean value of fHA was
used in the individual experiments (Section 2, below). For
the calculations of the model-derived dual-input, e CPVðtÞ ,a
mean value for all experiments, denoted fHA (=0.25±0.07,
mean±SEM), was used (Section 5, below).
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the tracer concentration time-courses in HA blood, CHA(t),
equivalent to the individually measured tracer concentration
time-courses in arterial blood, CA(t), and PV blood, CPV(t),
and fHA,a s
CdualðtÞ¼fHACAðtÞþð 1   fHAÞCPVðtÞð 2Þ
3. We describe the passage of a bolus from the arterial system
throughthesplanchniccirculationtothePVusingapreviously
validated impulse response function based on a distribution of
washoutrateconstants.Thefull impulseresponse function has
two parameters: a final washout rate constant, k0,a n dβ, that
determine the mean transit time and the standard deviation of
transit times for the passage of tracer from the intestinal
arteries to the PV [14]. Thus, the model parameters have a
clear physiological interpretation. In the limit of a slow final
washout constant, k0→0, the full impulse-response function
is reduced to a power law function with the single parameter
β. This one-parameter impulse response function provided a
robust description of the tracer concentration time-course in
the PV for CO and MG [14]. In the present study we
accordingly estimated β of this PV model for each tracer
administration by nonlinear regression analysis of the
relationship between CPV(t)a n dCA(t):
CPVðtÞ¼
Z t
0
hðt   tÞCAðtÞdt; hðtÞ¼b=ðt þ bÞ
2: ð3Þ
With CO and H2O, agreement between the double determi-
nations of β was good (see Results) and the mean value for
each animal was used.
4. The mean of β, denoted b, was used as an estimate of a
population mean of β for each tracer and used to calculate
individual PV model-derived tracer concentration time
courses in the PV, e CPVðtÞ, from CA(t) as:
e CPVðtÞ¼
Z t
0
hðt   tÞCAðtÞdt; hðtÞ¼b=ðt þ bÞ
2
ð4Þ
5. The model-derived dual-input, e CdualðtÞ, was calculated
from CA(t), e CPVðtÞ and fHA, as:
e CdualðtÞ¼fHACAðtÞþð 1   fHAÞe CPVðtÞð 5Þ
6. The use of e CdualðtÞ instead of Cdual(t) when estimating
hepatic tracer kinetics was assessed by means of individual
simulated tracer activity concentration time courses in liver
tissue, e CliverðtÞ, using the first 3 minutes of the measured
Cdual(t) and a one-tissue compartmental model with a fixed
set of ”true” parameters: K1
true, clearance of tracer from
blood to liver cells (1 ml blood per millilitre liver tissue per
minute); k2, rate constant for backflux of tracer from cells to
blood (2/min); and V0, vascular volume of the liver
(0.40 ml blood per millilitre liver tissue). The model was
fitted to e CliverðtÞ using the e CdualðtÞ as input for estimation of
K1
est with no parameters fixed. The error associated with
the use of e CdualðtÞ rather than Cdual(t) in the kinetic fitting
procedure was assessed by the relative deviation of K1
est
from K1
true:( K1
est − K1
true)/K1
true, which assesses how well
the fixed K1
true is recovered. Although the one-tissue
compartmental model was not physiologically correct for all
tracers in the present study, we used it to generate a simulated
tissue curve for testing the effect of replacing Cdual(t)b y
e CdualðtÞ in the analysis of initial hepatic tracer kinetics.
Statistical analysis
Normally distributed data are expressed in terms of the
mean ± standard error of the mean (SEM) unless otherwise
stated, and statistical analysis of intergroup differences was
performed by ANOVA analysis. For multiple comparisons,
the Bonferroni post-hoc test was used for data with equal
variance and the Tamhane T2 test for data with unequal
variance. Differences with a p value <0.05 were considered
statistically significant.
Results
Examples of the measured tracer concentration time-course
in the PV, CPV(t), are shown in Fig. 1 (left) which illustrates
the delay and the dispersion of the peak compared to that in
arterial blood, CA(t). The e CPVðtÞ derived from the PV
model (Eq. 4) well reflects the measured CPV(t).
With CO (nine tracer administrations) the degree of
agreement between the double determinations of b, expressed
as an intraclass correlation, was 0.90. The corresponding
figure for H2O (five tracer administrations) was 0.86. Thus,
the estimate of β could be accurately reproduced in each
animal. For the administration of both FDG and MG in each
of six pigs two-way ANOVA showed that the variation
between the pigs accounted for 79.0% of the total variance
(p=0.0591). In other words, the accuracy of the estimated β
was good enough to demonstrate variation between the
animals. The variation associated with b accordingly can be
ascribed to physiological and experimental differences
between animals which contribute to the error of e CPVðtÞ.
The tracer-specific means of b, are shown in Table 1.T h e
rank order for b was CO<FDG≈MG<FDGal<H2O.
As illustrated in Fig. 1 (right), the dual input, e CdualðtÞ,
derived from the model (Eq. 5) well reflects the measured
dual input, Cdual(t)( E q .2). e CdualðtÞ even reproduced the
biphasic shape of Cdual(t) for CO. In some cases, e CdualðtÞ
266 Eur J Nucl Med Mol Imaging (2011) 38:263–270slightly over- or underestimated the peak value of Cdual(t)
more than would be expected from the good agreement
between e CPVðtÞ and CPV(t). No systematic tendencies were
apparent, probably because individual values of fHA were
used to calculate Cdual(t), whereas the mean value fHA was
used to calculate e CdualðtÞ.
The error associated with using e CdualðtÞ rather than Cdual(t)
to estimate K1
est did not differ significantly from zero with
any of the tracers (Table 2). Individual estimates of K1
est may,
however, be biased because the individual (unknown)
parameters β and fHA may deviate from the tracer-specific
mean b and the mean fHA for all tracer administrations. As an
example, Fig. 2 shows a plot of the error of K1
est as a function
of β and fHA for MG with b =0 . 5a n dfHA =0 . 2 5 .T h e r ew e r e
wide ranges of β and fHA values which only induce a modest
error in K1
est. In general, K1
est is overestimated when the
individual β is lower than b and vice versa.
Discussion
The main result of this study was that estimates of the time-
course of the model-derived e CdualðtÞ based on tracer-specific
means of β combined with the mean HA blood flow
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Fig. 1 Left Examples of blood
tracer activity concentration
time-courses following bolus
administration of tracers to pigs
measured in a femoral artery,
CA(t)( red curves); measured in
the PV, CPV(t)( blue curves); PV
model-derived, e CPVðtÞ(green
curves) calculated from CA(t)
using means of the tracer-
specific parameters for the pas-
sage of the tracer from the
intestinal arteries to the PV, bs
(Eq. 4). Right For each tracer,
the measured dual input, Cdual(t)
(blue curves), was calculated
from CA(t) and CPV(t) shown on
the left and the individually
measured HA blood flow frac-
tions, fHA (Eqs. 1 and 2). The
corresponding model-derived
dual input, e CdualðtÞ (green
curves), was calculated from
CA(t) and e CPVðtÞ and the mean
HA blood flow fraction, fHA
(=0.25; Eq. 5)
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The use of e CdualðtÞ instead of Cdual(t)t oe s t i m a t ec l e a r a n c e
of tracer from blood to liver cells, K1, was successful for all
tracers. Dual input of tracer to the liver can thus be estimated
solely by sampling blood from a peripheral artery, thereby
obviating the need to sample blood from the PVand perform
invasive measurement of blood flow.
The tracer-specific β (minutes) is related to the transit
time of tracer through the splanchnic circulation and may
be interpreted as the inverse of the most frequent rate
(min
−1) by which tracer molecules enter the PV blood-
stream from the intestinal arteries [14]. The study included
five tracers differing widely in splanchnic mean transit time
from purely intravascular CO to freely diffusible H2O. A
high mean transit time yields a high β, as reflected in the
rank order of b for the tracers, i.e. CO<FDG≈MG<FDGal
<H2O (Table 1). The low b for CO (0.10±0.02 min) is in
agreement with a low mean splanchnic transit time due to
firm binding to erythrocytes and with the previously
recorded value of 0.11±0.02 min in pigs [14]. b was
significantly higher for H2O than for all the other tracers
(p<0.0001), in accordance with the fact that water is freely
diffusible and thus has the greatest volume of distribution
and slowest passage through the splanchnic circulation, i.e.
a high transit time. Tracer-specific means of β, i.e. b, could
be estimated with all five tracers and the PV model
adequately described the transfer of the tracers from the
intestinal arteries to the PV, thus indicating general
applicability of the PV model.
The validity of the PV model relies on two assumptions:
(1) no trapping of tracer in the intestines, and (2) no
production of blood-born metabolites in the intestines. If one
of these assumptions is violated then there is no longer a mass
balance between the tracer activity concentration on the
arterial side and on the PV side, and this must be taken into
account, e.g. by multiplying a loss term to the impulse-
response function in Eq. 3. We did not include a loss term
because all five tracers in this study allowed direct use of the
PV model (Fig. 1, left). However, if other tracers are used
this modification may be required. Moreover, some PET
tracers, e.g.
13N-ammonia, produce blood-born metabolites
outside the intestines that must be taken into account when
analysing dynamic PET data of the liver [20]. For such
tracers the PV model should be applied separately for the
tracer and the metabolites.
The mean HA flow fraction found in this study, 0.25, is
similar tothe value of0.26±0.02(n=7) determined in humans
with no liver disease by means of ultrasound transit-time
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Fig. 2 Plot of the error associated with the use of model-derived dual
input, e CdualðtÞ, rather than measured dual input, Cdual(t), (see Fig. 1,
right) for fitting hepatic kinetics. The plot provides an example with b
equal to that for MG (0.5 min) and fHA the mean of all experiments
(0.25), using a simulated activity concentration time-course in liver
tissue calculated according to a one-tissue compartmental model with
fixed K1
true (K1, clearance of tracer from blood to liver cells) using
Cdual(t) as input (see text for further details). Next K1
est was estimated
by fitting the model to the simulated liver tissue curve using e CdualðtÞ
as input. The relative deviation of K1
est from K1
true,( K1
est−K1
true)/
K1
true, illustrates how well the fixed K1
true is recovered by K1
est, and is
plotted as a function of sets of β (tracer-specific parameter of the PV
model, minutes) and fHA (HA blood flow fraction)
Table 2 Fractional error of model-derived clearance of tracer from
blood to liver cells
Tracer No. of studies K1
est fractional error
a p value
CO 9 0.02±0.05 0.71
FDG 6 0.23±0.23 0.36
MG 6 -0.04±0.09 0.67
FDGal 10 -0.09±0.13 0.51
H2O 5 0.17±0.09 0.16
aModel-derived dual input was validated by comparing the estimated
clearance of tracer from blood to liver cells, K1
est, with the fixed “true”
clearance, K1
true. K1
est was calculated by fitting a one-tissue compartmen-
tal liver kinetic model to a simulated tracer concentration time-course in
liver tissue, e CliverðtÞ, using the model-derived dual input, e CdualðtÞ; see text
for further details. The data are presented as means±SEM.
Table 1 Values of b (tracer-specific means of β) in pigs. The data are
presented as means±SEM
Tracer Number of tracer administrations b (min)
CO 9 0.10±0.02
FDG 6 0.50±0.05
MG 6 0.57±0.09
FDGal 10 0.82±0.08
H2O 5 2.17±0.13
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healthy humans by hepatic scintiangiography [22]. This
indicates that a HA flow fraction of 0.25 is applicable to
human studies. Likewise, the mean transit time for CO
through the splanchnic circulation determined in pigs, 0.35±
0.05 min [21], is similar to that in humans, 0.37±0.05 min
[22]. These similarities for key physiological features are
promising for translation of the present modelling to human
studies, but this needs to be examined further.
A key question is to what extent will possible errors
introduced by the use of the model-derived dual input,
e CdualðtÞ, rather than the measured dual input, Cdual(t),
propagate into errors of the estimated liver kinetic param-
eters. We examined this question by using simulated liver
tissue activity concentration time-courses rather than
experimental PET data, the rationale being that simulated
data are not influenced by the experimental uncertainty
associated with measured activity concentration time-
course in liver tissue or the possible shortcomings of
compartmental models of hepatic tracer kinetics. We
therefore generated a simulated activity concentration
time-course in liver tissue, e CliverðtÞ, using a one-tissue
compartmental model of the hepatic tracer kinetics with
fixed “true” parameters and the “correct” individually
invasively measured dual input, Cdual(t). The model was
then fitted to the simulated liver tissue curve e CliverðtÞ using
e CdualðtÞ to test how well the fixed “true” parameter K1
true
could be reproduced. Full kinetics of experimentally
measured PET data should be analysed using kinetic
models appropriate to the metabolism of the specific tracer
[1–3, 18, 19]. For the evaluation of the PV model, however,
all five tracers distribute flow-limited in the liver and
therefore the use of the one-tissue compartmental model is
relevant for the initial kinetics for all five tracers.
The finding that the mean deviation of K1
est from K1
true
was not significantly different from zero for any of the five
tracers (Table 2) demonstrates that the modelling of the
dual input yielded accurate estimates of K1 for each group
of tracer experiments. The next question is to what extent
the error in K1 for individual subjects depends on the
individual (unknown) values of β and fHA compared with b
and fHA. Fig. 2 gives an example of how deviation in true
individual β and fHA from fHA and b propagate into errors
of K1
est. The relationship is complicated due to correlations
between the one-tissue compartmental model parameters
(K1, k2, V0) and the model-derived dual-input parameters b
and fHA. Nevertheless, wide ranges of β and fHA exist that
only induce a modest error in K1
est. However, large
deviations in β from b and in fHA from fHA will lead to
significant errors in the estimation of K1. This emphasizes
the importance of using a well-established set of b and fHA
when performing kinetic analyses without PV blood
samples. Thus, the model-derived dual input e CdualðtÞ can
only be used for a group of subjects for whom estimates of
b and fHA are available.
Compared to previous models [4, 7–13], our method is
very robust, relying on only a single tracer-specific
parameter b. It makes no assumption about the shape of
the arterial input curve, is independent of the liver kinetic
model and is unaffected by possible undesirable features of
the PET image-derived input such as partial volume effects
and artefacts due to patient motion. The robustness of the
model and the similarities between the splanchnic circula-
tion in pigs and humans indicate the potential for
transferring the method to PET studies of initial tracer
kinetic processes such as blood-cell exchange and hepatic
blood perfusion in liver physiology and metabolism in
humans.
Conclusion
In the present study we developed a method to estimate a
model-derived dual-input using the one-parametric PV-
model, a tracer-specific mean parameter b for the transfer
of tracer from the intestinal arteries to the PV and the HA
blood flow fraction fHA = 0.25. Although the five tracers
examined here differ markedly in splanchnic mean transit
time, the PV-model could be successfully applied to each
of the tracers. Validation of the model for a wide range of
tracers did not reveal any systematic deviations in
parameters of the initial hepatic tracer kinetics by using
the model-derived compared with the invasively measured
dual-input. The study thus shows that the dual input of
tracer to the liver from the HA and PV can be well
approximated without the necessity to sample blood from
the PV and perform invasive measurement of blood flow
in the HA and PV. Our new method only requires
measurement of the tracer concentration in a peripheral
artery during a dynamic PET study of the liver and
estimates of the mean fHA and tracer-specific population
mean b.
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